Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Compared with placebo, candesartan therapy significantly lowered plasma levels of monocyte chemoattractant protein-1 from the respective baseline levels (p = 0.003). Open circles = mean values.
|
